In its latest report on RSV Diagnostic Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players.
RSV Diagnostic Market Size
Global RSV Diagnostic Market is valued at USD 767.8 Million in 2020 and expected to reach USD 1465.1 Million by 2027 with a CAGR of 9.67% over the forecast period.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/1592
Scope of Global Respiratory Syncytial Virus (RSV) Diagnostics Market:
Respiratory syncytial virus is a very common and contagious virus which infects respiratory track of most children before 1-2 year of their age. RSV was discovered from chimpanzee BY J. Morris and associate in 1956. RSV is an enveloped RNA virus of family Paramyxoviridae which causes lung infections. It affects all generations but it is very dangerous for infants and older infants.
RSV is most common cause of bronchiolitis and pneumonia. It also causes respiratory illness in adults and it can occasionally causes serious infection that needs hospitalization from breathing compromise with bronchiolitis or pneumonia. In most of the people, symptoms usually develops after 4-6 days of exposure to RSV which is known as incubation period of RSV virus. Symptoms of RSV includes runny nose, loss of appetite followed by coughing or sneezing or mild fever. Also in infants sometimes develop serious symptoms like wheezing, irritability, cyanosis and breathing difficulties. RSV spreads person to person via coughing or sneezing. For diagnosis, mostly doctors use blood or urine test to look for a bacterial infection, chest x-ray for checking any signs of pneumonia, test of material scraped out from persons nose or, mouth. In treatment of RSV of infants doctors uses cool mist vaporizer to keep the air moist and make breathing easier. Also non aspirin fever reducer tablets are used. In serious cases, doctors use IV fluid or medications to open the air ways.
Covid-19 has shown a positive impact on the growth of global RSV diagnostics market owing to the increasing prevalence of Covid-19 cases which is also a respiratory diseases. And RSV is also a contagious respiratory infection. Thus, some of the players are offering and producing RSV diagnostic kits with combination to Covid-19 testing. For example; on January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample.
Request for Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1592
The regions covered in this Global RSV diagnostic market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of RSV diagnostic is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Respiratory Syncytial Virus (RSV) Diagnostic Companies
Some major key players of global RSV diagnostics market are
- Becton
- Dickinson and Company
- Novartis diagnostics
- Abbott laboratories
- ortho clinical diagnostics
- Thermo fisher scientific inc.
- Bio-rad laboratories inc.
- Hoffmann la Roche limited
- Biomerieux
- Diasorin spa
- Emd Millipore
- Quidel corporation
- Alere inc.
- Coris bioconcept
- fast-track diagnostics
- Quest diagnostics and others.
Respiratory Syncytial Virus (RSV) Diagnostic News:
New All-in-One Test for COVID-19/Flu/RSV
On January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample. The TCA/GENETWORx Flu A-B/COVID Combo Test is a molecular diagnostic PCR test that detects two types of influenza viruses; influenza A and B and differentiates them from RSV, and SARS-CoV-2, the virus that causes COVID-19. The Flu A-B/COVID Combo Test provided by GENETWORx has a 98% accuracy rate for influenza, 99% for COVID-19, and 96% for RSV.
Increasing Prevalence of Respiratory Diseases and Rising Prevalence of Covid-19 Cases are the Major Factors Driving the Market Growth
Increasing prevalence of respiratory diseases, growing demand of POC test kits and increasing cases of pneumonia like disease in infants or in geriatric population driving the growth of the market. For example; according to American Lung Association, infants have high risk of developing RSV. About 5%-10% infants are getting affected by RSV and 25%-40% people having bronchitis and pneumonia have chances to develop RSV in them. This respiratory syncytial virus can passes from one person to other. It enters the body through the eyes, nose or mouth. This virus can infect people by coughing or sneezing and also from shaking hands. In addition, growing demand of POC test for diagnosis of RSV infections is also propelling the growth of the market. As main feature of POC testing is rapidity. It provides immediate information to physician about patients’ health condition. These tests are effective in case of RSV to check the infection. Therefore growing demand of POC test for diagnosis is propelling the growth of the market. Furthermore, increasing number of product offerings by key players is also fostering the market growth. For instance; in March 2020 Roche diagnostics launch cobas liat POC device. This device shows excellent analytical performance to detect influenza A, influenza B and RSV, and it is considered as easy to use. Also adults having chronic disorders or weak immune system have high risk of developing RSV.
However, lack of awareness among the parents about its diagnostics especially in rural areas may hamper the growth of the market. In spite of that, advancement in diagnostic technology can offer more opportunities for the further growth of the market.
Complete Report Details @ https://brandessenceresearch.com/healthcare/rsv-diagnostic-market
Key Benefits of Global Respiratory Syncytial Virus (RSV) Diagnostics Market:
- Global RSV Diagnostics Market report covers in-depth historical and forecast analysis.
- Global RSV Diagnostics Market research report provides detail information about Market Introduction, Market Summary, Global market, Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
- Global RSV Diagnostics Market report helps to identify opportunities in
- Global RSV Diagnostics Market report covers extensive analysis of emerging trends and competitive.
Segmentation Analysis:
Global RSV diagnostic market is segmented on the basis of type, method, end user and regional & country level. On the basis of type, market is classified into kits, instruments and others. On the basis of method, market is classified into molecular diagnostics and rapid antigen detection tests. On the basis of end-user, the market is classified into hospitals, clinics, clinical labs and home care.
Global RSV Diagnostics Market Segmentation:-
By Type:
- Kits
- Instruments
- Others
By Methods:
- Molecular Diagnostics
- Rapid Antigen Detection Tests
- Enzyme-Linked Immunosorbent Assays
- Immunofluorescence Assays
- Other Rapid Antigen Detection Tests
By End-User:
- Hospitals, clinics
- Clinical labs
- Home care
By Regional & Country Analysis: (North America, U.S., Canada, Europe, U.K., France, Germany, Italy,Asia Pacific, China, Japan, India, Southeast Asia, Latin America, Brazil, Mexico, Middle East and Africa, GCC, Africa, Rest of Middle East and Africa)
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global RSV Diagnostic Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global RSV Diagnostic Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. RSV Diagnostic Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
3. Chapter – Global RSV Diagnostic Market Overview: Quantitative Analysis
4. Chapter – Global RSV Diagnostic Market Analysis: Segmentation By Type
5. Chapter – Global RSV Diagnostic Market Analysis: Segmentation By Application
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com
Website: https://brandessenceresearch.com/
Article: https://businessstatsnews.com
Related Report:
Waste to Energy Market Size:Global demand for (WTE) Waste to Energy Market Size, in terms of revenue, was worth of USD 32.15 Billion in 2017 and is expected to reach USD 49.44 Billion in 2027, growing at a CAGR of 4.4% from 2021 to 2027.
Vaccines Vials Market Size: The global vaccines vials market in terms of revenue was worth of USD 459.6 Million in 2020 and is expected to reach USD 901.3 Million in 2027, growing at a CAGR of 10.1% from 2021 to 2027.
